Pharmafile Logo
Pharmafocus logo
Advanced Search

Government to limit pharmacy reform

October 29, 2003

News

Roche survey shows cancer postcode prescribing continues

October 29, 2003

A new UK-wide survey by Roche has shown a third of breast cancer patients who could benefit from its NICE-approved …

News

Limited lifting of NICE ‘ban’ on Tamiflu

October 29, 2003
Sales and Marketing

Roche have won a limited recommendation for its flu drug Tamiflu following a second NICE approval.An appraisal of flu drugs …

News

The new GP contract : incentives for pharma too

October 29, 2003
GP contract, NHS, healthcare

As the final details of the new GP contract are decided, the pharmaceutical industry is now preparing itself for a …

Feature

Betaferon and Avonex in head-to-head MS trial

October 29, 2003
Research and Development, Sales and Marketing

Schering AG is to launch the largest ever therapeutic multiple sclerosis trial, comparing its drug Betaferon with Biogen's rival Avonex.The …

News

AstraZeneca accused of blocking Losec competition

October 29, 2003
Sales and Marketing

News

Aventis awards ClinPhone preferred supplier status

October 29, 2003
Research and Development

Aventis has made ClinPhone its preferred provider for data management of it clinical trials worldwide.Specialists in telephone and internet-based electronic …

News

Do doctors really use the Internet?

October 29, 2003
Sales and Marketing doctors, internet

Ever since the medical and pharmaceutical web emerged in the mid-90s, technology advocates have assumed that widespread use of the …

Feature

Celltech takes 10% stake in OGS

October 29, 2003
Sales and Marketing

News

New GSK joint venture malaria drug approved

October 29, 2003
Research and Development

News

Zyprexa approved for bipolar disorder

October 29, 2003
Sales and Marketing

Eli Lilly's market-leading schizophrenia drug Zyprexa has been granted European approval for the long-term treatment of bipolar disorder.The approval makes …

News

New HRT study shows doubling of cancer risk

October 29, 2003
Research and Development

A new study of over one million UK women has confirmed an increased risk of breast cancer from all forms …

News

Retaining the talent you recruit

October 29, 2003
Business Services recruitment, strategy

The vast majority of people who want to work in the pharma industry have high ideals and wish to be …

Feature

Merck expands into US proteomics

October 29, 2003
Research and Development

Merck KGaA has bought ProtoPlex, a US-based biotech company specialising in functional genomics and proteomics.Privately owned Protoplex will be integrated …

News

Shire cuts back ahead of US expansion

October 29, 2003
Sales and Marketing

Shire Pharmaceuticals is to revert to its original business model of marketing and developing specialist drugs in late stage clinical …

News

Genzyme buys SangStat for $600m

October 29, 2003
Research and Development

US biotech company Genzyme is to buy SangStat, a California-based company whose lead product Thymoglobulin is a $77 million-a-year treatment …

News

Pfizer/Pharmacia mega-merger gains final clearance

October 29, 2003
Sales and Marketing

The creation of a new pharmaceutical goliath is now just days away after Pfizer and Pharmacia received final regulatory clearance …

News

AstraZeneca prepares Crestor for battle

October 29, 2003
Sales and Marketing

AstraZeneca's US salesforce is gearing up to launch its potential blockbuster cholesterol-reducing drug Crestor, after receiving a long-awaited FDA approval.Crestor …

News

Yamanouchi reinforces US future with GSK deal

October 29, 2003
Sales and Marketing

Japanese pharma company Yamanouchi has struck a deal to co-market its forthcoming overactive bladder treatment with GlaxoSmithKline in the US. …

News

Troubled UK biotechs to merge

October 29, 2003
Research and Development

News
The Gateway to Local Adoption Series

Latest content

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026

Medicus Pharma’s Teverelix shows positive efficacy and safety in premenopausal women

January 13, 2026